World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
94
Citations
30094
World Ranking
10538
National Ranking
5422

Overview

Marcos de Lima is affiliated with The Ohio State University in the United States and has contributed extensively to the field of medicine, with a strong focus on hematology and oncology. Their research spans over 383 publications, with significant work in subfields such as hematology, oncology, public health, genetics, and immunology.

The main topics of Marcos de Lima's research include:

  • CAR-T cell therapy research
  • Hematopoietic Stem Cell Transplantation
  • Acute Myeloid Leukemia Research
  • Acute Lymphoblastic Leukemia research
  • Chronic Myeloid Leukemia Treatments
  • Multiple Myeloma Research and Treatments
  • Immune Cell Function and Interaction

They have published frequently in several specialized venues, demonstrating ongoing contributions in their areas of expertise. The most frequent publication venues include:

  • Blood
  • Transplantation and Cellular Therapy
  • Bone Marrow Transplantation
  • Biology of Blood and Marrow Transplantation
  • Clinical Lymphoma Myeloma & Leukemia

Marcos de Lima has collaborated with various co-authors over their career. Notable frequent co-authors include:

  • Paolo F. Caimi
  • Leland Metheny
  • Ehsan Malek
  • Wael Saber
  • Folashade Otegbeye

Several recent papers illustrate their research focus, including:

  • NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021, 2021, Journal of the National Comprehensive Cancer Network
  • A phase 3 randomized study of 5-azacitidine maintenance vs observation after transplant in high-risk AML and MDS patients, 2020, Blood Advances
  • Harnessing the immune system to overcome cytokine storm and reduce viral load in COVID-19: a review of the phases of illness and therapeutic agents, 2020, Virology Journal
  • Prophylactic Tocilizumab Prior to Anti-CD19 CAR-T Cell Therapy for Non-Hodgkin Lymphoma, 2021, Frontiers in Immunology
  • Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology, 2020, Journal of the National Comprehensive Cancer Network

Best Publications

  • Transplants of Umbilical-Cord Blood or Bone Marrow from Unrelated Donors in Adults with Acute Leukemia

    Vanderson Rocha;Myriam Labopin;Guillermo Sanz;William Arcese

  • Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

    Jyoti D. Patel;Lada Krilov;Sylvia Adams;Carol Aghajanian

  • Once-daily intravenous busulfan and fludarabine: clinical and pharmacokinetic results of a myeloablative, reduced-toxicity conditioning regimen for allogeneic stem cell transplantation in AML and MDS

    Marcos de Lima;Daniel Couriel;Peter F. Thall;Xuemei Wang

  • Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

    Marcos J.G. de Lima;Sergio Giralt;Peter F. Thall;Leandro De Padua Silva

  • Acute myeloid leukemia, version 3.2017: Clinical practice guidelines in oncology

    Margaret R. O'Donnell;Martin S. Tallman;Camille N. Abboud;Jessica K. Altman

  • Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

    Marcos J.G. de Lima;Ian McNiece;Simon N. Robinson;Mark Munsell

  • Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation

    Marcos De Lima;Athanasios Anagnostopoulos;Mark Munsell;Munir Shahjahan

  • Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure

    Michel Duval;John P. Klein;Wensheng He;Jean Yves Cahn

  • Hematopoietic cell transplantation–specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

    Mohamed L. Sorror;Sergio Giralt;Brenda M. Sandmaier;Brenda M. Sandmaier;Marcos J.G. de Lima

  • Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.

    Issa F Khouri;Peter McLaughlin;Rima M Saliba;Chitra Hosing

  • Acute myeloid leukemia, version 3.2019

    Martin S. Tallman;Eunice S. Wang;Jessica K. Altman;Frederick R. Appelbaum

  • Delayed immune reconstitution after cord blood transplantation is characterized by impaired thymopoiesis and late memory T-cell skewing

    Krishna V. Komanduri;Lisa S. St. John;Marcos J.G. de Lima;John McMannis

  • Survival of Patients with Acute Myeloid Leukemia Relapsing after Allogeneic Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Study

    Nelli Bejanyan;Daniel J. Weisdorf;Brent R. Logan;Brent R. Logan;Hai Lin Wang

  • Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

    Christopher G. Kanakry;Paul V. O'Donnell;Terry Furlong;Marcos J. De Lima

  • Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

    Elihu Estey;Marcos de Lima;Raoul Tibes;Sherry Pierce

  • Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial.

    M. de Lima;J. McMannis;A. Gee;K. Komanduri

  • Extracorporeal photochemotherapy for the treatment of steroid resistant chronic GVHD

    Daniel R. Couriel;Chitra Hosing;Rima M Saliba;Elizabeth Shpall

  • Tumor necrosis factor-α blockade for the treatment of acute GVHD

    Daniel Couriel;Rima Saliba;Krystal Hicks;Cindy Ippoliti

  • High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.

    Stefan O. Ciurea;Marcos J.G. de Lima;Pedro Cano;Martin Korbling

  • Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Celso A. Rodrigues;Guillermo Sanz;Claudio G. Brunstein;Jaime Sanz

Frequent Co-Authors

Richard E. Champlin
Richard E. Champlin The University of Texas MD Anderson Cancer Center
Sergio Giralt
Sergio Giralt Memorial Sloan Kettering Cancer Center
Partow Kebriaei
Partow Kebriaei The University of Texas MD Anderson Cancer Center
Elizabeth J. Shpall
Elizabeth J. Shpall The University of Texas MD Anderson Cancer Center
Borje S. Andersson
Borje S. Andersson The University of Texas MD Anderson Cancer Center
Issa F. Khouri
Issa F. Khouri The University of Texas MD Anderson Cancer Center
Daniel J. Weisdorf
Daniel J. Weisdorf University of Minnesota
Mei-Jie Zhang
Mei-Jie Zhang Medical College of Wisconsin
Hillard M. Lazarus
Hillard M. Lazarus Case Western Reserve University
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a future in medicine but looking for alternative or complementary routes, there are several online degrees and career pathways worth exploring. For those interested in nursing, there are nursing programs without TEAS that make entry into this rewarding field more accessible, especially for those who want to avoid standardized test barriers.

If management and leadership roles appeal to you, a healthcare administration degree online accredited can open doors to administrative and executive roles in hospitals, clinics, or public health organizations.

Registered nurses seeking career advancement or expanded clinical responsibilities can consider ADN to NP bridge programs to become nurse practitioners without starting over.

Nutrition and wellness is another vital area in healthcare. If dietary science interests you, check out the best online food science degree programs and explore careers in public health, sports medicine, or wellness coaching. These diverse online options provide flexible ways to enter or grow in the health professions.

Best Scientists Citing Marcos de Lima

Trending Scientists

Recently Published Articles